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Coronary angioplasty continues to be limited by a 30% 
restenosis rate within 6 months. Postmortem histopatho- 
logic studies uggest that the intimally directed migration 
and proliferation of vascular smooth-muscle c lls (VSMC) 
may play a critical role in this problem. These studies, 
however, can provide only limited static information re- 
garding a specific moment in the disease process. To over- 
come this limitation and to look at the underlying mecha- 
nisms involved, we used directional coronary atherectomy 
to percutaneously retrieve tissue from patients with clin- 
ically and angiographically documented coronary artery 
disease and examined the hypothesis that VSMC cultured 
from restenotic lesions differ in extracellular matrix syn- 
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thesis from primary atherosclerotic cells. Our experimen- 
tal strategy was first to culture the tissue segment and 
confirm the identity of the explant cells and then to com- 
pare extracellular matrix synthesis between primary and 
restenotic ells. 
Methods. A total of 98 in vivo plaque specimens were ob- 
tained from 98 patients undergoing directional coronary 
atherectomy with a previously described standard tech- 
nique. 1 Tissue specimens were cultured with standard ex- 
plant techniques. Smooth-muscle c ll outgrowth was as- 
sessed by light microscopy with morphologic criteria rein- 
forced by electron microscopy and positive immunostaining 
against specific smooth-muscle c ll ~-actin. Extracellular 
matrix synthesis was sessed by studying the Synthesis 
of collagen and sulfated aminoglycans, the principal com- 
ponents of the extracellular matrix. To determine collagen 
synthesis growth, arrested cells of passage 2 to 4 were in- 
cubated for 48 hours at 37 ° C in culture medium contain- 
ing 2 pmol/L ascorbic acid and 10 ~Ci.ml -z 3H-proline 
(specific activity 23 mCi.mg-1). To determine sulfated gly- 
cosaminoglycans synthesis growth, arrested cells were 
incubated for 48 hours at 37 ° C in culture medium 
containing 0.5 ml 35S-sulfate (specific a tivity 20 mCi- 
.mg-1). Subsequent analyses were performed with previ- 
ously described techniques.1 Measurements are expressed 
as mean -+ SEM. Mean values were compared by the Stu- 
dent's t test for unpaired ata. Data were considered sig- 
nificant ifp < 0.05. 
Results. Initial cell outgrowth and successful secondary 
culture (up to seven serial passages) was achieved in 11 
patients, 7 with primary and 4 with restenotic lesions. 
Cells started to grow out from explants after 4 to 8 days 
(Fig. 1), and confluent multilayer primary cultures from 
the 11 patients were established after 4 to 6 weeks. Sub- 
confluent cultures took the form of a network of multilay- 
ered elongated cells, whereas in confluent multilayer 
structures the cells appeared as whorls, producing the "hill 
and valley" pattern typical of vascular smooth-muscle c lls 
in culture (Fig. 1). Immunostaining of the cells for a-actin 
was positive and confirmed them to be of smooth-muscle 
origin. Electron microscopy revealed features consistent 
with the synthetic phenotype. Collagen synthesis, re- 
flected by the incorporation of3H-proline, was significantly 
greater for cells of restenotic than primary origin 
(0.034 -+ 0.002 vs 0.024 - 0.001 nmol [3H]-proline • pg to- 
tal cell protein -z, n = 11, p < 0.05) (Fig. 1). Similarly, pro- 
duction of sulfated aminoglycans a assessed by the incor- 
poration of 35S-sulfate was significantly greater for rest- 
enotic than primary cells (7.49 ± 0.58 vs 5.11 ± 0.48 nmol 
[3H]-sulphate • ~g total cell protein -z, n = 11, p < 0.05) 
(Fig. 1). 
Comments. Our study has demonstrated that restenotic 
cells synthesize significantly more collagen and sulfated 
aminoglycans than do primary cells, suggesting that ex- 
tracellular matrix synthesis may play a significant role in 
postangioplasty restenosis. This finding is in contrast o 
our previous tudy, zin which we found that restenotic and 
primary cells synthesized more extracellular matrix pro- 
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Fig. 1. Upper left panel, Fragment of retrieved atherectomy tissue in culture showing dense population 
of VSMC migrating out of explant (Original magnification x60). Upper right panel, "Hill and valley" pat- 
tern typical of vascular smooth-muscle c lls in culture. Lower left panel, Production of extracellular ma- 
trix collagen. Lower right panel, Production of extracellular matrix sulfated aminoglycans. *p < 0.05. 
tein than did human umbilical vein cells, but no differences 
were seen between the two. This finding is likely to have 
occurred because of the significantly higher proliferation 
rate in restenotic ells during those experiments. In this 
study, in which we looked for differences in extracellular 
matrix synthesis during growth arrest, we found that re- 
stenotic ells synthesize significantly more extracelhilar 
matrix than do primary cells. 
Because the difference in extracellular matrix synthesis 
between primary and restenotic cell l ines occurred under 
identical culture conditions, we believe that the secretory 
behavior of the restenotic cells in vitro reflects a previous 
phenomenon of phenotypic modulation and selection in 
vivo rather than some effect of the culture process itself. 2 
In support of this belief are histopathologic studies that 
suggest that smooth-muscle c lls in both primary athero- 
sclerotic and restenotic lesions are frequently of the syn- 
thetic phenotype. Additionally, coronary smooth-muscle 
cells in tissue excised at atherectomy have been recently 
shown to express messenger RNA for nonmuscle myosin 
heavy chain, which is associated with the synthetic smooth- 
muscle cell phenotype. 3 
Our data suggest that restenotic cells are fundamental ly 
different from primary atherosclerotic cells in the produc- 
tion of extracellular matrix, n keeping with previous 
studies uggesting that resten0tic cells differ from primary 
cells in terms of their migratory activity, 4 growth regula- 
tion, 1 and motility. 5This finding may be a reflection of a 
more specialized function of the VSMC situated in the res- 
tenotic lesion, which may have been activated as a result 
of the angioplasty procedure itself in the response to injury 
hypothesis. Alternatively, it may signify a selected popu- 
lation of already activated VSMC in lesions that have sub- 
sequently undergone restenosis. The small numbers in- 
volved preclude us from commenting on which of the two 
mechanisms i  most likely, but both are likely to involve 
the induction of growth factors such as transforming 
growth factor-~, the expression of which has been shown 
to be increased in restenotic lesions. 6 This finding is in 
keeping with our data and would suggest hat the in- 
creased expression of transforming growth factor-~ may 
result in increased production of extracellular matrix. This 
study has demonstrated that coronary smooth-muscle cells
obtained from in vivo restenotic lesions synthesize signif- 
icantly more extracellular matrix than do cells from 
primary lesions, suggesting that increased extracellular 
matrix production may play a fundamental role in rest- 
enosis after angioplasty. 
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Recurrent non-Q-wave myocardial 
infarction associated with toluene abuse 
Tanveer F. Hussain, MD, Paul A. Heidenreich, MD, and 
Neal Benowitz, MD San Francisco, Calif. 
Toluene, a common substance of solvent abuse in the 
United States, is associated with significant cardiac mor- 
bidity and mortal i ty after inhalation. Several reports have 
described cardiac omplications ofacute (arrhythmia, my- 
ocardial infarction 1) and chronic intoxication (dilated car- 
diomyopathy2). We report the case of a 55-year-old man 
with toluene-related recurrent non-Q-wave myocardial 
infarction. 
The pat ient is a 55-year-old Hawai ian man who first 
came to medical attention in March 1992 when he arr ived 
with dyspnea on exertion, paroxysmal nocturnal dyspnea, 
orthopnea, peripheral edema, and vague chest discomfort. 
He gave a history of alcohol abuse but no tobacco r illicit 
drug use. On physical examination he was noted to have 
a blood pressure of 204/136, bibasi lar ales, an elevated 
jugular  venous pressure, and mild peripheral edema. An 
electrocardiogram demonstrated normal sinus rhythm 
and left ventricular hypertrophy with repolarization ab- 
normalities. Serial creatinine kinase determinations re- 
vealed a peak level of 94 IU/L with an elevated MB frac- 
tion. A chest x-ray examination showed cardiomegaly, and 
an echocardiogram demonstrated a left ventricular ejec- 
tion fraction of 45% with mild global hypokinesis and mild 
concentric left ventricular hypertrophy. A thal l ium exer- 
cise treadmil l  test demonstrated an inferior wall defect at 
exercise, but the pat ient did not return for a rest study. 
Cardiac catheterization revealed normal coronary arter- 
ies. Results of a complete blood count, electrolytes, and 
liver function tests were within normal limits, and a uri- 
nalysis was notable for mild proteinuria (30 mg/dl). The 
pat ient was successfully treated with a combination of ni- 
trates, diuretics, calcium channel blocker, and an angio- 
tensin-converting enzyme inhibitor. However, he was fre- 
quently noted to be noncompliant with his medications. 
From the Departments of Medicine at the University of California, San 
Francisco, and the San Francisco General Hospital, San Francisco, Califor- 
nia. 
Reprint requests: Paul A. Heidenreich, MD, Division of Cardiology, Box 
0!24, University of California, San Francisco, 505 Parnassus, San Fran~ 
cisco, CA 94143. 
AM HEART J 1996;131:615-6. 
Copyright © 1996 by N[osby-Year Book, Inc. 
0002-8703/96/$5.00 +  4/4/68323 
Since that initial visit the patient has had 11 admissions 
for non-Q-wave myocardial infarction over an 18-month 
period. His presentations to the emergency department 
were for acute episodes of severe substernal chest pain 
with radiation to the left arm; these episodes lasted more 
than 30 minutes, often occurred at rest and were associ- 
ated with nausea and diaphoresis. Admitt ing blood pres- 
sure varied from 135 to 200 mm Hg, and mild congestive 
heart  failure was frequently noted on examination and 
chest radiography. Occasional transient electrocar- 
diographic hanges showed pseudonormalization f the 
T-wave abnormalit ies orST depression. Over t ime echocar- 
diographic studies showed decreased left ventricnlar ejec- 
tion fraction from 45% to 33%. He underwent wo addi- 
tional cardiac catheterizations, again revealing normal 
coronary arteries. An ergonovine challenge test or myo- 
cardial biopsy was not performed. Throughout his time 
the results of his complete blood count, electrolytes, and 
liver function tests were within normal imits except for a 
trend toward hypokalemia nd mild proteinuria. His tol- 
uene abuse was detected uring his tenth admission for 
non-Q-wave myocardial infarction, when he was found 
saturat ing paper towels with industr ial  strength toluene 
in preparat ion for "sniffing" in the hospital. When con- 
fronted, the patient admitted to inhaling toluene in a sim- 
i lar manner one to two times per week since 1968, often 
immediately before chest pain developed. On the last 
recorded admission for non-Q-wave myocardial infarction, 
his electrolytes were notable for an anion gap acidosis with 
hypokalemia (Na 138, K 2.8, C1 106, CO2 13). A urinalysis 
showed worsening proteinuria (300 mg/dl) and numerous 
hyaline casts. The electrolyte abnormalit ies returned to 
normal at discharge. 
The cardiac toxicity of toluene most frequently described 
in the l i terature is arrhythmia, specifically ventricular 
tachycardia, ventricular fibrillation, and sinus bradycar- 
dia, often leading to sudden death. 3Possible mechanisms 
of action include oversensitization f the heart  to endoge- 
nous catecholamines and direct slowing of the sinoatrial 
node. 4 Coexisting electrolyte abnormalit ies caused by tol- 
uene's renal toxicity may also contribute to the develop- 
ment of these fatal arrhythmias. 5 Less commonly reported 
is the presence of dilated cardiomyopathy with toluene 
abuse. 2
Acute myocardial infarction has rarely been reported in 
the setting of solvent abuse. One case report describes a
16-year-old boy who had ventricular fibril lation and an 
anterior myocardial infarction shortly after prolonged in- 
1 halation of an adhesive containing toluene. We believe our 
case to be the first l inking toluene abuse to recurrent my- 
ocardial infarction. We postulate that acute exposure to 
toluene led to coronary vasospasm caused by increased 
sensitivity to catecholamines, 4 with the subsequent devel- 
opment of non-Q-wave myocardial infarction. The patient 
admitted to toluene use before the onset of the acute 
symptoms, l inking the two processes temporally. Moreover 
the development of both an anion gap acidosis with 
hypokalemia nd proteinuria is consistent with distal tu- 
bular acidosis, which is a well-known phenomenon i tol: 
uene abuse. 6
